Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in RZLT — Rezolute, Inc.

CIK 886982 NEW YORK, NY
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,847,265
+$5,010,263 QoQ
Shares Held
1,316,782
+118.6% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 144 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Derivatives in RZLT

reported options exposure · as of Dec 31, 2025
CallValue
$59,000
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RZLT ranks #177 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in RZLT

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,847,265 1,316,782
2026-03-31 $1,837,002 602,296
2025-12-31 $59,000 25,000
2025-12-31 $3,079,284 1,304,782
2025-09-30 $5,089,977 541,487
2025-06-30 $147,643 33,104
2025-03-31 $685,005 236,209